Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial.
Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial.
复制标题
DOI：
10.1186/1471-244x-13-312
复制
发表时间：
2013-11-18
期刊：
影响因子：
4.4
通讯作者：
Hadzi-Pavlovic D
中科院分区：
文献类型：
--
作者：
Proudfoot J;Clarke J;Birch MR;Whitton AE;Parker G;Manicavasagar V;Harrison V;Christensen H;Hadzi-Pavlovic D
基于手机的心理干预可以实现实时自我监测、自我管理和大规模传播。然而，很少有研究关注公共卫生需求最大的轻至中度症状，也没有一项研究以工作和社会功能为目标。本研究报告了一项符合 CONSORT 标准的随机对照试验 (RCT) 的结果，旨在评估 myCompass 的功效，myCompass 是一种通过手机和电脑提供的自我指导心理治疗，旨在减少轻度至中度抑郁、焦虑和压力，并改善工作和社交功能。患有轻度至中度抑郁、焦虑和/或压力的社区志愿者 (N = 720) 被随机分配到 myCompass 计划（注意力控制干预措施）或等待名单条件七周。干预措施完全自动化，无需任何人工输入或指导。使用抑郁、焦虑和压力量表以及工作和社会适应量表在基线、干预后和 3 个月随访时评估参与者的症状和功能。研究样本在干预后和随访时的保留率分别为 72.1% (n = 449) 和 48.6% (n = 350)。在 7 周干预阶段结束时，与两个对照条件相比，myCompass 组在抑郁、焦虑和压力症状以及工作和社会功能方面表现出显着改善（根据观察到的平均值，组间效应大小范围为 d = .22 到 d = .55）。在 3 个月的随访中，症状评分仍保持在接近正常水平。注意力控制条件下的参与者在干预后阶段表现出逐渐改善的症状，并且在 3 个月的随访中，他们的分数与 myCompass 组没有差异。 myCompass 计划是一项有效的公共卫生计划，有助于患有轻度至中度心理健康问题的个人快速改善症状、工作和社会功能。澳大利亚新西兰临床试验注册中心 ACTRN 12610000625077
Mobile phone-based psychological interventions enable real time self-monitoring and self-management, and large-scale dissemination. However, few studies have focussed on mild-to-moderate symptoms where public health need is greatest, and none have targeted work and social functioning. This study reports outcomes of a CONSORT-compliant randomised controlled trial (RCT) to evaluate the efficacy of myCompass, a self-guided psychological treatment delivered via mobile phone and computer, designed to reduce mild-to-moderate depression, anxiety and stress, and improve work and social functioning. Community-based volunteers with mild-to-moderate depression, anxiety and/or stress (N = 720) were randomly assigned to the myCompass program, an attention control intervention, or to a waitlist condition for seven weeks. The interventions were fully automated, without any human input or guidance. Participants’ symptoms and functioning were assessed at baseline, post-intervention and 3-month follow-up, using the Depression, Anxiety and Stress Scale and the Work and Social Adjustment Scale. Retention rates at post-intervention and follow-up for the study sample were 72.1% (n = 449) and 48.6% (n = 350) respectively. The myCompass group showed significantly greater improvement in symptoms of depression, anxiety and stress and in work and social functioning relative to both control conditions at the end of the 7-week intervention phase (between-group effect sizes ranged from d = .22 to d = .55 based on the observed means). Symptom scores remained at near normal levels at 3-month follow-up. Participants in the attention control condition showed gradual symptom improvement during the post-intervention phase and their scores did not differ from the myCompass group at 3-month follow-up. The myCompass program is an effective public health program, facilitating rapid improvements in symptoms and in work and social functioning for individuals with mild-to-moderate mental health problems. Australian New Zealand Clinical Trials Registry ACTRN 12610000625077